Glenmark Pharmaceuticals Statistics

Total Valuation

BOM:532296 has a market cap or net worth of INR 462.58 billion. The enterprise value is 470.25 billion.

Market Cap	462.58B
Enterprise Value	470.25B

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Sep 13, 2024

Share Statistics

Current Share Class	282.20M
Shares Outstanding	n/a
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+2.98%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	142.26M

Valuation Ratios

The trailing PE ratio is 44.18 and the forward PE ratio is 26.83.

PE Ratio	44.18
Forward PE	26.83
PS Ratio	3.44
PB Ratio	5.23
P/TBV Ratio	6.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.08, with an EV/FCF ratio of -29.82.

EV / Earnings	44.91
EV / Sales	3.50
EV / EBITDA	19.08
EV / EBIT	23.76
EV / FCF	-29.82

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.28.

Current Ratio	1.56
Quick Ratio	0.85
Debt / Equity	0.28
Debt / EBITDA	1.00
Debt / FCF	-1.57
Interest Coverage	9.56

Financial Efficiency

Return on equity (ROE) is 12.54% and return on invested capital (ROIC) is 12.13%.

Return on Equity (ROE)	12.54%
Return on Assets (ROA)	8.14%
Return on Invested Capital (ROIC)	12.13%
Return on Capital Employed (ROCE)	19.63%
Revenue Per Employee	8.96M
Profits Per Employee	698,577
Employee Count	14,989
Asset Turnover	0.88
Inventory Turnover	1.57

Taxes

In the past 12 months, BOM:532296 has paid 3.52 billion in taxes.

Income Tax	3.52B
Effective Tax Rate	25.16%

Stock Price Statistics

The stock price has increased by +34.30% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+34.30%
50-Day Moving Average	1,458.52
200-Day Moving Average	1,534.89
Relative Strength Index (RSI)	74.11
Average Volume (20 Days)	50,874

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532296 had revenue of INR 134.35 billion and earned 10.47 billion in profits. Earnings per share was 37.10.

Revenue	134.35B
Gross Profit	90.82B
Operating Income	19.79B
Pretax Income	13.99B
Net Income	10.47B
EBITDA	24.65B
EBIT	19.79B
Earnings Per Share (EPS)	37.10

Full Income Statement

Balance Sheet

The company has 17.05 billion in cash and 24.73 billion in debt, giving a net cash position of -7.67 billion.

Cash & Cash Equivalents	17.05B
Total Debt	24.73B
Net Cash	-7.67B
Net Cash Per Share	n/a
Equity (Book Value)	88.49B
Book Value Per Share	304.50
Working Capital	33.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.28 billion and capital expenditures -7.50 billion, giving a free cash flow of -15.77 billion.

Operating Cash Flow	-8.28B
Capital Expenditures	-7.50B
Free Cash Flow	-15.77B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.60%, with operating and profit margins of 14.73% and 7.79%.

Gross Margin	67.60%
Operating Margin	14.73%
Pretax Margin	10.41%
Profit Margin	7.79%
EBITDA Margin	18.35%
EBIT Margin	14.73%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.15%.

Dividend Per Share	2.50
Dividend Yield	0.15%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	6.73%
Buyback Yield	-0.02%
Shareholder Yield	0.13%
Earnings Yield	2.26%
FCF Yield	-3.41%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.

Last Split Date	Sep 10, 2007
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	5